Novo Nordisk ( NVO 1.34%) and Regeneron Pharmaceuticals ( REGN -0.27%), two leading drugmakers, have underperformed for most ...

Elon Musk sees "rough quarters." A likely "robotaxi" launch in San Francisco comes with caveats. BYD is near a buy point.

On a Mission to Dominate British chip design titan Arm Holdings (NASDAQ:ARM) sent shockwaves through the tech industry ...

Crocs is undervalued as investors overreact to HEYDUDE challenges and tariffs, overlooking strong brand power and resilience.

At the risk of sounding like investing guru Cathie Wood, Tesla (NASDAQ:TSLA) has a clear path to be a $20 trillion stock. The pioneer in electric vehicles (EVs) and sustainable energy has transformed ...

Management is guiding for 2025 sales of $73.75 billion to $74.75 billion and free cash flow of $6.6 billion to $6.8 billion.

Harley-Davidson faces declining demand, high rates, and tariffs, eroding profits. See why analysts are issuing a 'sell' ...

Beyond is at the bottom for Revenue Growth with -39.38%, while the peers have positive growth rates. Beyond also has the lowest Gross Profit at $58.13M, compared to the higher figures of its peers.

Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using ...

The disclosure sent UNH shares tumbling 4.7%, reflecting investor unease with the ongoing troubles with the healthcare stock.

CFOs looking to go public soon must nail forecasting, defend their most critical KPIs and incorporate pricing discipline in ...

Centene stock tumbled after reporting a surprise Q2 loss, driven by rising medical costs and a weak outlook, shaking ...